Home › NCT07713940

Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* patients who meet the 2019 EULAR/ACR Classification Criteria for SLE
* patients who are on Cellcept or Myfortic for at least 3 months prior to screening
* patients with a score of ≥55 on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain interference scale.

Exclusion Criteria:

* pregnant or lactating patients,
* patients with food allergy
* patients on antibiotics within 4 weeks of the screening
* patients that change the SLE therapy during the length of the study (12 weeks).

About the study

To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus

What is being tested

• anti-inflammatory diet (dietary supplement)

Sponsor: University of California, San Diego · Participants: 36 · Started: Jul 1, 2026

Contact the study team

• Monica Guma, MD, PhD · Phone: 858-822-6523

Official record on ClinicalTrials.gov — NCT07713940

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.